Patents by Inventor Chongnian Luo

Chongnian Luo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8586108
    Abstract: The present invention relates to plant extracts, specifically, the extracts of Chinese medicine Chenopodium ambrosioides L. and the composition comprising thereof. The extracts of Chinese medicine Chenopodium ambrosioides L. are prepared by conventional methods for the extraction of volatile oil, and can be used to treat Helicobacter Pylori-induced diseases of digestive system, such as gastritis, gastric ulcer, etc., with easy availability of raw materials, simple preparations, prominent effects, and less side-effect.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: November 19, 2013
    Assignee: Tasly Pharmaceutical Group Co., Ltd
    Inventors: Zhengliang Ye, Yonghong Zhu, Ying Zhao, Dekun Li, XiaoLi Zheng, Chongnian Luo, Feng Wei, GuangMing Zhang, JianMing Chen, Jun Gao, JunFeng Xiong
  • Publication number: 20130178516
    Abstract: The present invention relates to plant extracts, specifically, the extracts of Chinese medicine Chenopodium ambrosioides L. and the composition comprising thereof. The extracts of Chinese medicine Chenopodium ambrosioides L. are prepared by conventional methods for the extraction of volatile oil, and can be used to treat Helicobacter Pylori -induced diseases of digestive system, such as gastritis, gastric ulcer, etc., with easy availability of raw materials, simple preparations, prominent effects, and less side-effect.
    Type: Application
    Filed: December 21, 2012
    Publication date: July 11, 2013
    Applicant: Tasly Pharmaceutical Group Co., Ltd.
    Inventors: Feng Wei, Zhengliang Ye, Jun Gao, Chongnian Luo, Dekun Li, Jianming Chen, Yonghong Zhu, Junfeng Xiong, Xiaoli Zheng, Guangming Zhang, Ying Zhao
  • Patent number: 8361515
    Abstract: The present invention relates to plant extracts, specifically, the extracts of Chinese medicine Chenopodium ambrosioides L. and the composition comprising thereof. The extracts of Chinese medicine Chenopodium ambrosioides L. are prepared by conventional methods for the extraction of volatile oil, and can be used to treat Helicobacter Pylori-induced diseases of digestive system, such as gastritis, gastric ulcer, etc., with easy availability of raw materials, simple preparations, prominent effects, and less side-effect.
    Type: Grant
    Filed: December 29, 2006
    Date of Patent: January 29, 2013
    Assignee: Tasly Pharmaceutical Group Co., Ltd.
    Inventors: Feng Wei, Zhengliang Ye, Jun Gao, Chongnian Luo, Dekun Li, Jianming Chen, Yonghong Zhu, Junfeng Xiong, Xiaoli Zheng, Guangming Zhang, Ying Zhao
  • Publication number: 20090130203
    Abstract: The present invention relates to plant extracts, specifically, the extracts of Chinese medicine Chenopodium ambrosioides L. and the composition comprising thereof. The extracts of Chinese medicine Chenopodium ambrosioides L. are prepared by conventional methods for the extraction of volatile oil, and can be used to treat Helicobacter Pylori-induced diseases of digestive system, such as gastritis, gastric ulcer, etc., with easy availability of raw materials, simple preparations, prominent effects, and less side-effect.
    Type: Application
    Filed: December 29, 2006
    Publication date: May 21, 2009
    Applicant: Tianjin Tasly Pharmaceutical Co. Ltd.
    Inventors: Feng Wei, Zhengliang Ye, Ju Gao, Chongnian Luo, Dekun Li, Jiangming Chen, Yonghong Zhu, Junfeng Xiong, Xiaoli Zheng, Guangming Zhang, Ying Zhao
  • Patent number: 7438935
    Abstract: The present invention discloses a pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases which comprises Radix Salviae Miltiorrhizae extract 5.0%-70.0%, Radix Notoginseng extract 10.0%-85.0%, Radix Astragali extract 5.0%-70.0%, and Bomeol or oil of Lignum Dalbergiae Odoriferae 1.0%-15.0%. The composition is active against cerebral ischemia and myocardial ischemia. The effects are superior to total phenic acid of Radix Salviae Miltiorrhizae or total saponin of Radix Notoginseng respectively, or the combination thereof. The composition of the invention can provide various kinds of preparations by the addition of various accessories. Thus the invention provides a more effective and convenient composition of TCM effective sections and its preparations.
    Type: Grant
    Filed: September 23, 2004
    Date of Patent: October 21, 2008
    Assignee: Tianjin Tasly Pharmaceutical Co., Ltd.
    Inventors: Feng Wei, Dekun Li, Chongnian Luo, Hongshui Yue, Qingchuang Chen, Zhijuan Huang
  • Publication number: 20070053999
    Abstract: The present invention discloses a pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases which comprises Radix Salviae Miltiorrhizae extract 5.0%-70.0%, Radix Notoginseng extract 10.0%-85.0%, Radix Astragali extract 5.0%-70.0%, and Bomeol or oil of Lignum Dalbergiae Odoriferae 1.0%-15.0%. The composition is active against cerebral ischemia and myocardial ischemia. The effects are superior to total phenic acid of Radix Salviae Miltiorrhizae or total saponin of Radix Notoginseng respectively, or the combination thereof. The composition of the invention can provide various kinds of preparations by the addition of various accessories. Thus the invention provides a more effective and convenient composition of TCM effective sections and its preparations.
    Type: Application
    Filed: September 23, 2004
    Publication date: March 8, 2007
    Inventors: Feng Wei, Dekun Li, Chongnian Luo, Hongshui Yue, Qingchuang Chen, Zhijuan Huang